Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Giliganoes99on Jul 23, 2021 1:35pm
245 Views
Post# 33596688

Cultivating Innovative Success for CBD

Cultivating Innovative Success for CBD
Sponsored Post
 
Regardless of controversial histories with the CBD industry, and looking at the current stand of how the industry itself is going in the global market, it is probably undeniable that its potentials are making noise. Entirely, the goal is said to be delivering a potentially effective set of treatments using products infused with CBD. The world seems to be open to the industry's potential availability over the counter, globally in the future. But, are you? If you're having positive thoughts about this, then what else could this article bring forth to you?
 
As years pass by, researches regarding CBD seem to be displaying good results. This has been one of the reasons why stigma in its usage has not been as bad as before. More people could then be able to see the potential benefits of the products, and that could mean probable market success as well. With the possible legalization of the plant's usage in the United States, the potential of approximately $40billion TAM supply and demand gap might be created.
 
Needless to say, the industry could potentially be facing numerous possible positive outcomes at this state. And though the potentials are already alluring as it is, there still possibly be yet to discover about the plant and its possible benefits. Interested enough to kind of feel this is a bit of a cliffhanger? Proceeding to this article could be sufficient to sustain your curiosity!
 
Check disclaimer on profile and landing page.
<< Previous
Bullboard Posts
Next >>